Submissions should focus on innovative solutions with the potential to improve outcomes and experiences using devices, diagnostics, consumer products, products for healthcare professionals, digital healthcare or healthcare IT to directly treat or manage transplants, or support overall physical and mental well-being.
ABOUT THE SUMMIT AND AWARD
The goal of the 2021 Lyfebulb-CSL Behring Innovation Challenge: Thriving with Transplantation is to source innovative solutions to improve outcomes and experiences for all those affected by transplantation.
The Innovation Challenge will take place virtually in May 2021 and is currently accepting applications through February 19, 2021. Patient entrepreneurs – those who have been affected by chronic disease as either a patient or support partner for a loved one and started a company to develop solutions to an unmet need identified in their disease journey – are encouraged to apply.
Selected finalists will receive an invitation to pitch their company’s solutions to an expert panel of judges comprised of healthcare industry, medical and patient leaders. One winner will be awarded a $25,000 monetary grant. Competing finalists may be considered for possible partnerships or investments beyond the challenge. Beyond presenting their innovative ventures, the finalists will have the opportunity to exchange ideas on how to further advance patient innovation in the transplant community; engage with Lyfebulb founders, CSL Behring leadership leadership, representatives from the patient community, key opinion leaders and potential investors; and share insights with each other.
The Lyfebulb-CSL Behring Innovation Challenge stems from the idea of the Lyfebulb Entrepreneur Circle, established in 2015, and features individuals who have created a product and a company based on the issues encountered due to their personal experiences with a chronic illness (through their own diagnosis or that of a loved one).
Dr. Nick Housby
Co-Founder & CEO at Accunea
Dra. Isabel Portero
Founder & CEO at Biohope Scientific Solutions
Co-Founder at HeartBrothers Foundation
Co-Founder & CEO at HeroKi
Co-Founder & CEO at IKONA Health
Dr. Ann Chokas
Founder at Life4ward
CEO at Lifeina
Dr. Minnie Sarwal
Founder & CEO at Nephrosant
Co-Founder & CEO at Ochre Bio
Co-Founder & COO at RealTime Clinic
Lloyd E. Ratner, MD, MPH, FACS
Professor of Surgery, Director, Renal and Pancreatic Transplantation at Columbia University Medical Center
Stephen Squinto, PhD
Executive Partner at OrbiMed, Co-Founder at Alexion, and Co-Founder & Chairman at Lyfebulb
Chief Technology Officer at United Network for Organ Sharing (UNOS)
Transplant Patient Ambassador at Lyfebulb and Marriage and Family Therapist Associate at Healing the Hurt Consulting
Managing Director at Symbiotix at Havas Health & You
The judging panel will assess the following:
- What is the strategic basis for the identified problem/gap (e.g., research conducted)?
- How is the problem/gap being specifically addressed?
- Does the innovation have the potential to improve the lives of people affected by transplantation?
- How great of an impact (market impact and patient impact) will the innovation make and how will it be measured?
- How is the product or service unique to the market?
- What is the feasibility of development and implementation into the marketplace (e.g., funding, regulations, requirements for testing)?
APPLYING FOR THE INNOVATION CHALLENGE
The solution may address the following:
- Directly treating or managing transplant
- Supporting overall physical and mental well-being
- Patients (recipients), donors, families, and loved ones
- Medical community and society
STAGE OF JOURNEY
- All stages of the journey from pre-transplantation through long-term management
THE CHALLENGE IN NUMBERS
Applications open on Wednesday, January 7, 2021
Applications close on Friday, February 19, 2021, at 11:59 PM EDT
Finalists will be pitch their solutions over the course of a two day summit May 12-13, 2021
One entrepreneur will be awarded the 2021 Lyfebulb-CSL Behring Innovation Award, including a $25,000 monetary grant to grow their company